HU163631B - - Google Patents

Info

Publication number
HU163631B
HU163631B HUSU616A HUSU000616A HU163631B HU 163631 B HU163631 B HU 163631B HU SU616 A HUSU616 A HU SU616A HU SU000616 A HUSU000616 A HU SU000616A HU 163631 B HU163631 B HU 163631B
Authority
HU
Hungary
Application number
HUSU616A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU163631B publication Critical patent/HU163631B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/28—Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/30—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings
    • C07D243/32—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings containing a phthalimide or hydrogenated phthalimide ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUSU616A 1970-04-23 1971-04-23 HU163631B (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP45035735A JPS494226B1 (cg-RX-API-DMAC10.html) 1970-04-23 1970-04-23

Publications (1)

Publication Number Publication Date
HU163631B true HU163631B (cg-RX-API-DMAC10.html) 1973-09-27

Family

ID=12450072

Family Applications (1)

Application Number Title Priority Date Filing Date
HUSU616A HU163631B (cg-RX-API-DMAC10.html) 1970-04-23 1971-04-23

Country Status (6)

Country Link
JP (1) JPS494226B1 (cg-RX-API-DMAC10.html)
AT (1) AT302315B (cg-RX-API-DMAC10.html)
CH (1) CH559730A5 (cg-RX-API-DMAC10.html)
CS (1) CS167310B2 (cg-RX-API-DMAC10.html)
HU (1) HU163631B (cg-RX-API-DMAC10.html)
ZA (1) ZA712391B (cg-RX-API-DMAC10.html)

Also Published As

Publication number Publication date
AT302315B (de) 1972-10-10
ZA712391B (en) 1972-01-26
CS167310B2 (cg-RX-API-DMAC10.html) 1976-04-29
CH559730A5 (en) 1975-03-14
JPS494226B1 (cg-RX-API-DMAC10.html) 1974-01-31

Similar Documents

Publication Publication Date Title
DK142349C (cg-RX-API-DMAC10.html)
FR2104397A5 (cg-RX-API-DMAC10.html)
FR2098528A5 (cg-RX-API-DMAC10.html)
FR2091375A5 (cg-RX-API-DMAC10.html)
FR2100677A1 (cg-RX-API-DMAC10.html)
FR2065630A1 (cg-RX-API-DMAC10.html)
FR2078079A5 (cg-RX-API-DMAC10.html)
FR2135684A5 (cg-RX-API-DMAC10.html)
FR2076466A5 (cg-RX-API-DMAC10.html)
FR2101697A5 (cg-RX-API-DMAC10.html)
DK142469C (cg-RX-API-DMAC10.html)
FR2078089A5 (cg-RX-API-DMAC10.html)
FR2098572A5 (cg-RX-API-DMAC10.html)
FR2152574B2 (cg-RX-API-DMAC10.html)
FR2075014A5 (cg-RX-API-DMAC10.html)
AU3330871A (cg-RX-API-DMAC10.html)
JPS491167Y1 (cg-RX-API-DMAC10.html)
FR2066352A5 (cg-RX-API-DMAC10.html)
DK142154C (cg-RX-API-DMAC10.html)
DK136983C (cg-RX-API-DMAC10.html)
FR2089085A5 (cg-RX-API-DMAC10.html)
DK138357C (cg-RX-API-DMAC10.html)
FR2103511B1 (cg-RX-API-DMAC10.html)
DK138220C (cg-RX-API-DMAC10.html)
JPS4911645Y1 (cg-RX-API-DMAC10.html)